Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses (Q64377680)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Marjorie Robert-Guroff

12

object named as

Marjorie Robert-Guroff

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Nina V Malkevitch

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

L Jean Patterson

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

M Kristine Aldrich

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yichen Wu

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

David Venzon

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ruth H Florese

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

V S Kalyanaraman

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ranajit Pal

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Eun Mi Lee

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Jun Zhao

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Anthony Cristillo

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

0 references

publication date

30 June 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

353

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

83-98

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Cytotoxic T lymphocytes specific for the simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

CD8+ cell anti-HIV activity: nonlytic suppression of virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in M

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Defining the Protective Antibody Response for HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

A mixture model with detection limits for regression analyses of antibody response to vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

A helical epitope in the C4 domain of HIV glycoprotein 120

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

A synthetic conformational epitope from the C4 domain of HIV Gp120 that binds CD4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Characterization of HIV-1-specific T-helper cells in acute and chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Mechanisms of protection induced by attenuated simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2006.05.012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814356%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64377680&oldid=1507652234"